Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4508870
Author(s) Badertscher, Patrick; Boeddinghaus, Jasper; Nestelberger, Thomas; Twerenbold, Raphael; Wildi, Karin; Sabti, Zaid; Puelacher, Christian; Rubini Giménez, Maria; Pfäffli, Julian; Flores, Dayana; du Fay de Lavallaz, Jeanne; Miró, Òscar; Martin-Sanchez, F. Javier; Morawiec, Beata; Lohrmann, Jens; Buser, Andreas; Keller, Dagmar I.; Geigy, Nicolas; Reichlin, Tobias; Mueller, Christian
Author(s) at UniBasel Müller, Christian
Year 2018
Title Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin
Journal Clinical chemistry
Volume 64
Number 3
Pages / Article-Number 515-525
Abstract There is concern that high-sensitivity cardiac troponin (hs-cTn) may have low diagnostic accuracy in patients with low acute coronary syndrome (ACS) probability.; We prospectively stratified patients presenting with acute chest discomfort to the emergency department (ED) into 3 groups according to their probability for ACS as assessed by the treating ED physician using a visual analog scale: ≤10%, 11% to 79%, and ≥80%, reviewing all information available at 90 min. hs-cTnT and hs-cTnI concentrations were determined in a blinded fashion. Two independent cardiologists adjudicated the final diagnosis.; Among 3828 patients eligible for analysis, 1189 patients had low (≤10%) probability for ACS. The incidence of non-ST-segment elevation myocardial infarction (NSTEMI) increased from 1.3% to 12.2% and 54.8% in patients with low, intermediate, and high ACS probability, respectively. The positive predictive value of hs-cTnT and hs-cTnI was low in patients with low ACS probability and increased with the incidence of NSTEMI, whereas the diagnostic accuracy of hs-cTnT and hs-cTnI for NSTEMI as quantified by the area under the curve (AUC) was very high and comparable among all 3 strata, e.g., AUC hs-cTnI, 0.96 (95% CI, 0.94-0.97); 0.87 (95% CI, 0.85-0.89); and 0.89 (95% CI, 0.87-0.92), respectively. Findings were validated using bootstrap analysis as an alternative methodology to define ACS probability. Similarly, higher hs-cTnT/I concentrations independently predicted all-cause mortality within 2 years (e.g., hs-cTnT hazard ratio, 1.39; 95% CI, 1.27-1.52), irrespective of ACS probability.; Diagnostic and prognostic accuracy and utility of hs-cTnT and hs-cTnI remain high in patients with acute chest discomfort and low ACS probability. ClinicalTrials.gov Identifier: NCT00470587.
Publisher American Association for Clinical Chemistry
ISSN/ISBN 0009-9147 ; 1530-8561
edoc-URL https://edoc.unibas.ch/71163/
Full Text on edoc Available
Digital Object Identifier DOI 10.1373/clinchem.2017.279513
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/29343534
ISI-Number WOS:000426295200018
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.358 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
03/05/2024